-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
CARsgen Therapeutics Holdings Limited (HKG:2171) Insiders Who Sold CN¥38m Worth of Stock Earlier This Year Are Probably Glad They Did so as Market Cap Slides to HK$6.9b
CARsgen Therapeutics Holdings Limited (HKG:2171) Insiders Who Sold CN¥38m Worth of Stock Earlier This Year Are Probably Glad They Did so as Market Cap Slides to HK$6.9b
By selling CN¥38m worth of CARsgen Therapeutics Holdings Limited (HKG:2171) stock at an average sell price of CN¥13.40 over the last year, insiders seemed to have made the most of their holdings. After the stock price dropped 14% last week, the company's market value declined by HK$1.1b, but insiders were able to mitigate their losses.
Although we don't think shareholders should simply follow insider transactions, we do think it is perfectly logical to keep tabs on what insiders are doing.
View our latest analysis for CARsgen Therapeutics Holdings
CARsgen Therapeutics Holdings Insider Transactions Over The Last Year
The insider, Zhi Yang, made the biggest insider sale in the last 12 months. That single transaction was for HK$14m worth of shares at a price of HK$14.36 each. While insider selling is a negative, to us, it is more negative if the shares are sold at a lower price. It's of some comfort that this sale was conducted at a price well above the current share price, which is HK$12.16. So it is hard to draw any strong conclusion from it. The only individual insider seller over the last year was Zhi Yang.
Zhi Yang ditched 2.86m shares over the year. The average price per share was CN¥13.40. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. By clicking on the graph below, you can see the precise details of each insider transaction!
SEHK:2171 Insider Trading Volume September 22nd 2022If you are like me, then you will not want to miss this free list of growing companies that insiders are buying.
Insiders At CARsgen Therapeutics Holdings Have Sold Stock Recently
The last quarter saw substantial insider selling of CARsgen Therapeutics Holdings shares. In total, insider Zhi Yang dumped HK$23m worth of shares in that time, and we didn't record any purchases whatsoever. Overall this makes us a bit cautious, but it's not the be all and end all.
Insider Ownership
For a common shareholder, it is worth checking how many shares are held by company insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. It appears that CARsgen Therapeutics Holdings insiders own 4.9% of the company, worth about HK$338m. We've certainly seen higher levels of insider ownership elsewhere, but these holdings are enough to suggest alignment between insiders and the other shareholders.
So What Do The CARsgen Therapeutics Holdings Insider Transactions Indicate?
An insider hasn't bought CARsgen Therapeutics Holdings stock in the last three months, but there was some selling. Looking to the last twelve months, our data doesn't show any insider buying. It is good to see high insider ownership, but the insider selling leaves us cautious. While we like knowing what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. Every company has risks, and we've spotted 5 warning signs for CARsgen Therapeutics Holdings (of which 1 makes us a bit uncomfortable!) you should know about.
But note: CARsgen Therapeutics Holdings may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
通過出售價值3800萬元的CN卡斯根治療控股有限公司(HKG:2171)股票過去一年的平均售價為13.40元,內部人士似乎充分利用了他們所持的股份。在上週股價下跌14%後,該公司市值縮水11億港元,但內部人士能夠減輕他們的損失。
儘管我們不認為股東應該簡單地跟蹤內幕交易,但我們確實認為,密切關注內部人士的所作所為是完全合乎邏輯的。
查看我們對Carsgen Treateutics Holdings的最新分析
Carsgen Treateutics Holdings去年的內幕交易
知情人楊智在過去12個月裏進行了最大規模的內幕交易。這一筆交易是以每股14.36港元的價格購入價值1400萬港元的股票。雖然內幕出售是負面的,但對我們來説,如果股票以更低的價格出售,負面影響就更大。令人欣慰的是,此次出售的價格遠遠高於目前12.16港元的股價。因此,很難從中得出任何強有力的結論。過去一年裏唯一的個人內幕賣家是智揚。
智揚在一年中拋售了286萬股。每股均價為13.40加元。你可以在下面看到過去12個月(由公司和個人)進行的內幕交易的直觀描述。通過點擊下面的圖表,你可以看到每一筆內幕交易的準確細節!
聯交所:2022年9月22日內幕交易量2171如果你像我一樣,你會的不想懷念這一切嗎?免費內部人士正在收購的成長型公司名單。
CARsgen治療控股公司的內部人士最近出售了股票
上個季度,內幕人士大量拋售了CARsgen治療控股公司的股票。在此期間,知情人智洋總共拋售了價值2300萬港元的股票,而我們沒有記錄任何買入。總體而言,這讓我們有點謹慎,但這並不是一切。
內部人持股
對於一個普通股股東來説,公司內部人士持有多少股份值得一查。內部人持股比例較高往往會讓公司領導層更加關注股東利益。似乎CARsgen Treateutics Holdings的內部人士擁有該公司4.9%的股份,價值約3.38億港元。我們當然在其他地方看到了更高水平的內部人持股,但這些持股足以表明內部人和其他股東之間的關係。
那麼,Carsgen Treateutics Holdings的內幕交易表明了什麼?
一位內部人士在過去三個月裏沒有購買CARsgen治療控股公司的股票,但有一些拋售。展望過去12個月,我們的數據並未顯示有任何內部人士買入。看到高內部人持股是件好事,但內部人拋售讓我們保持謹慎。雖然我們喜歡知道內部人士的所有權和交易情況,但在做出任何投資決定之前,我們也要確保考慮到一隻股票面臨的風險。每家公司都有風險,我們已經發現Carsgen Treateutics Holdings的5個警告信號(其中1個讓我們有點不舒服!)你應該知道。
但請注意:Carsgen Treateutics Holdings可能不是買入的最佳股票。所以讓我們來看看這個免費高淨資產收益率和低負債的有趣公司名單。
就本文而言,內部人是指向相關監管機構報告其交易的個人。我們目前負責公開市場交易和私人處置,但不包括衍生品交易。
對這篇文章有什麼反饋嗎?擔心內容嗎? 保持聯繫直接與我們聯繫。或者,也可以給編輯組發電子郵件,地址是implywallst.com。
本文由Simply Wall St.撰寫,具有概括性。我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論,我們的文章並不打算作為財務建議。它不構成買賣任何股票的建議,也沒有考慮你的目標或你的財務狀況。我們的目標是為您帶來由基本面數據驅動的長期重點分析。請注意,我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內。Simply Wall St.對上述任何一隻股票都沒有持倉。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧